4.2 Review

Response Rates A Valuable Signal of Promising Activity?

期刊

CANCER JOURNAL
卷 15, 期 5, 页码 361-365

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/PPO.0b013e3181bd045f

关键词

cancer; oncology; clinical trials; evaluations; response criteria; WHO; RECIST; phase II trials; phase III trials

类别

向作者/读者索取更多资源

A main criterion to identify activity in phase II studies is the response rates achieved in a well-defined subset of patients. The response could be defined as a measure of turner shrinkage. For 30 years, metric methods have been used to assess this response. The World Health Organization was the first organization to propose a unified definition for response status. Over time, the latter evolved and 10 years ago an international consensus panel proposed the Response Evaluation Criteria in Solid Tumors criteria. Although these guidelines for response assessment have limitations and biases, they have nevertheless been proven useful and advantageous. This article reviews those criteria and describes their use.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据